Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma

BACKGROUND: Neuroblastoma (NB) is the most frequent extracranial solid tumor in children. More than 50% of patients present with widespread (stage M) or refractory disease. In these patients, event-free and overall survival was improved by the addition of the anti-disialoganglioside antibody dinutux...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Immunother Cancer
Hoofdauteurs: Ehlert, Karoline, Hansjuergens, Ina, Zinke, Andreas, Otto, Sylke, Siebert, Nikolai, Henze, Guenter, Lode, Holger
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 2020
Onderwerpen:
Case Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7239695/
https://ncbi.nlm.nih.gov/pubmed/32414861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000540
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items